{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T01:47:33Z","timestamp":1778464053348,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Centre for Research and Development of Poland","award":["143\/R\/P01\/2007\/IT1"],"award-info":[{"award-number":["143\/R\/P01\/2007\/IT1"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.clinbiochem.2014.05.059","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T05:28:06Z","timestamp":1401686886000},"page":"1313-1315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Determination of duloxetine in human plasma with proven lack of influence of the major metabolite 4-hydroxyduloxetine"],"prefix":"10.1016","volume":"47","author":[{"given":"Micha\u0142","family":"Kaza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edyta","family":"Gilant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Filist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Szlaska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Pawi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr J.","family":"Rudzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2014.05.059_bb0005","author":"European Medicines Agency"},{"key":"10.1016\/j.clinbiochem.2014.05.059_bb0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.9758\/cpn.2013.11.1.28","article-title":"Pharmacokinetics and safety of duloxetine enteric-coated tablets in Chinese healthy volunteers: a randomized, open-label, single- and multiple-dose study","volume":"11","author":"Li","year":"2013","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.clinbiochem.2014.05.059_bb0015","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jchromb.2007.02.025","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometric method for the determination of the major metabolites of duloxetine in human plasma","volume":"852","author":"Satonin","year":"2007","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.clinbiochem.2014.05.059_bb0020","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/dmd.31.9.1142","article-title":"Metabolism, excretion and pharmacokinetics of duloxetine in healthy human subjects","volume":"31","author":"Lantz","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clinbiochem.2014.05.059_bb0025","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/bmc.2895","article-title":"Quantitative determination of duloxetine and its metabolite in rat plasma by HPLC-MS\/MS","volume":"27","author":"Chae","year":"2013","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.clinbiochem.2014.05.059_bb0030","series-title":"Guideline on bioanalytical method validation. (EMEA\/CHMP\/EWP\/192217\/2009)","article-title":"Committee for Proprietary Products for Human Use (CHMP)","author":"European Medicines Agency","year":"2011"},{"key":"10.1016\/j.clinbiochem.2014.05.059_bb0035","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1080\/10826079608005497","article-title":"High performance liquid chromatographic method for the determination of duloxetine and desmethyl duloxetine in human plasma","volume":"19","author":"Johnson","year":"1996","journal-title":"J Liq Chromatogr Related Technol"},{"key":"10.1016\/j.clinbiochem.2014.05.059_bb0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5414\/CPP43078","article-title":"Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects","volume":"43","author":"Suri","year":"2005","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clinbiochem.2014.05.059_bb0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jchromb.2007.05.031","article-title":"HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure","volume":"856","author":"Mercolini","year":"2007","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.clinbiochem.2014.05.059_bb0050","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1208\/aapsj0903040","article-title":"Confirmatory reanalysis of incurred bioanalytical samples","volume":"9","author":"Rocci","year":"2007","journal-title":"AAPS J"},{"key":"10.1016\/j.clinbiochem.2014.05.059_bb0055","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/j.jchromb.2010.09.022","article-title":"Development and validation of an HPLC-MS\/MS method to determine clopidogrel in human plasma. Use of incurred samples to test back-conversion","volume":"878","author":"Silvestro","year":"2010","journal-title":"J Chromatogr B"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014002872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014002872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:43:50Z","timestamp":1757864630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912014002872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":11,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0009912014002872"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.05.059","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of duloxetine in human plasma with proven lack of influence of the major metabolite 4-hydroxyduloxetine","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.05.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}